Literature DB >> 19407963

Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist.

Asghar Davood1, Ali Reza Nematollahi, Maryam Iman, Abbas Shafiee.   

Abstract

1,4-Dihydropyridines have been recognized as calcium channel agonist. Three new analogues of Bay K8644 in which the ortho trifluromethyl phenyl group at position 4 is replaced by the 4-(5)-Chloro-2-ethyl-5-(4)-imidazolyl substituent, were designed and synthesized as calcium channel agonist. For this propose, the structures of designed compounds were drawn by HYPERCHEM program. Conformations of the compounds were optimized through semi-empirical method followed by PM3 calculation. Then the crystalin stucture of L-type calcium channel was obtained from the Protein Data Bank (PDB) server. Docking calculations were carried out using Auto-Dock.4 program. The good interaction of our 1,4-DHP derivatives showed that they can be as possible calcium channel agonist agents. Finally compounds were synthesized according to a modified Hantzsch condensation procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407963     DOI: 10.1007/s12272-009-1401-0

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  4 in total

1.  Docking studies of phthalimide pharmacophore as a sodium channel blocker.

Authors:  Maryam Iman; Atefeh Saadabadi; Asghar Davood
Journal:  Iran J Basic Med Sci       Date:  2013-09       Impact factor: 2.699

2.  Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety.

Authors:  Maryam Iman; Asghar Davood; Mahboubeh Lotfinia; Golnoush Dehqani; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

3.  Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent.

Authors:  Maryam Iman; Asghar Davood; Golnoush Dehqani; Mahboubeh Lotfinia; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Docking, Synthesis and Anticonvulsant Activity of N-substituted Isoindoline-1,3-dione.

Authors:  Maryam Iman; Atefeh Saadabadi; Asghar Davood; Hamed Shafaroodi; Ali Nikbakht; Abdollah Ansari; Masood Abedini
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.